hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
Aughton K, Elander NO, Evans A, Jackson R, Campbell F, Costello E, Halloran CM, Mackey JR, Scarfe AG, Valle JW, Carter R, Cunningham D, Tebbutt NC, Goldstein D, Shannon J, Glimelius B, Hackert T, Charnley RM, Anthoney A, Lerch MM, Mayerle J, Palmer DH, Büchler MW, Ghaneh P, Neoptolemos JP, Greenhalf W.
Aughton K, et al. Among authors: cunningham d.
Cancers (Basel). 2021 Nov 17;13(22):5758. doi: 10.3390/cancers13225758.
Cancers (Basel). 2021.
PMID: 34830914
Free PMC article.